Regulation of renal cytochrome P450s by thyroid hormone in diabetic rats

S Imaoka1, M Nakamura, T Ishizaki

  • 1Laboratory of Chemistry, Osaka City University Medical School, Japan.

Biochemical Pharmacology
|December 14, 1993
PubMed

Insights

Thyroid hormone (T3) levels decrease in diabetic rats, increasing renal CYP4A2 and P450 K-2 expression. T3 treatment or insulin reversed these changes, suggesting thyroid hormone suppresses these P450s.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Pharmacology

Background:

  • Diabetes mellitus is associated with altered xenobiotic metabolism.
  • Renal cytochrome P450 (CYP) enzymes play a role in drug and endogenous compound metabolism.
  • Thyroid hormones influence various metabolic processes, but their effect on renal CYP expression in diabetes is not fully understood.

Purpose of the Study:

  • To investigate the impact of thyroid hormone levels on renal CYP4A2 and P450 K-2 expression in diabetic rats.
  • To determine if thyroid hormone treatment can modulate CYP expression altered by diabetes.

Main Methods:

  • Diabetes was induced in rats using streptozotocin.
  • CYP4A2, P450 K-2, and P450 K-4 expression levels were measured.
  • Lauric acid hydroxylation activity was assessed.
  • Serum thyroid hormone levels were analyzed.
  • Effects of thyroid hormone (T3) and insulin treatment on diabetic rats were evaluated.
  • Effects of thyroidectomy and subsequent T3 treatment were examined.

Main Results:

  • Diabetes induced renal CYP4A2 and P450 K-2, along with lauric acid hydroxylation activity.
  • Serum thyroid hormone levels were reduced in diabetic rats.
  • T3 or insulin treatment reversed the diabetes-induced increase in CYP4A2 and P450 K-2.
  • Thyroidectomy increased CYP4A2 and P450 K-2, an effect reversed by T3 administration.

Conclusions:

  • Renal CYP4A2 and P450 K-2 expression are negatively regulated by thyroid hormone.
  • The reduced thyroid hormone levels in diabetes contribute to the induction of these specific renal CYPs.
  • Thyroid hormone replacement therapy may offer a strategy to normalize altered renal CYP expression in diabetic conditions.

Related Concept Videos